|
The frontline indices extended gains and traded near the day?s high in mid-afternoon trade. The Nifty climbed above the 19,850 level. Pharma stocks witnessed a bit of selling pressure. At 14:28 IST, the barometer index, the S&P BSE Sensex, was up 92.75 points or 0.14% to 66,084.14. The Nifty 50 index added 76.70 points or 0.39% to 19,871.40. In the broader market, the S&P BSE Mid-Cap index gained 0.17% while the S&P BSE Small-Cap index advanced 0.13%. The market breadth was positive. On the BSE, 1,984 shares rose and 1,776 shares fell. A total of 176 shares were unchanged. Numbers to Track: The yield on India's 10-year benchmark federal paper fell 0.07% to 7.267 as compared with previous close 7.272. In the foreign exchange market, the rupee edged higher against the dollar. The partially convertible rupee was hovering at 83.34, compared with its close of 83.40 during the previous trading session. MCX Gold futures for 5 December 2023 settlement added 0.03% to Rs 61,556. The US Dollar index (DXY), which tracks the greenback's value against a basket of currencies, was up 0.09% to 103.29. The United States 10-year bond yield advanced 0.25% to 4.398. In the commodities market, Brent crude for January 2024 settlement rose 62 cents or 0.78% to $80.60 a barrel. Buzzing Index: The Nifty Pharma index declined 0.42% to 15,887.25. The index advanced 0.87% in the past trading session. Granules India (down 2.43%), Aurobindo Pharma (down 2.11%), Glenmark Pharmaceuticals (down 1.81%), Abbott India (down 1.42%) and Zydus Lifesciences (down 1.07%), Biocon (down 0.81%), Laurus Labs (down 0.78%), Cipla (down 0.61%), Natco Pharma (down 0.58%) and Torrent Pharmaceuticals (down 0.56%) slipped. On the other hand, Gland Pharma (up 1.5%) ,Glaxosmithkline Pharmaceuticals (up 0.94%) and Dr Reddys Laboratories (up 0.4%) gained. Powered by Capital Market - Live News
|